Catalent takes over Paragon Bioservices

Source: Dukascopy Bank SA
The drug developer Catalent is set to acquire the privately-owned, gene-therapy oriented Paragon Bioservices in a deal valued at $1.2B, according to the Wall Street Journal's report on Sunday.
Back to articles

Actual Topics

Mon, 15 Apr 2019 04:36:11 GMT

Waste Management to purchase smaller rival for $2.9B

The Wall Street Journal announced in its Sunday report that the Houston-based Waste Management would buy its smaller competitor Advanced Disposal Services in an all-cash deal worth $2.9B.

Mon, 15 Apr 2019 03:32:50 GMT

US to use all tools to keep Maduro accountable

The United States is set to use all political and economic tools at its disposal to keep Venezuela's President Nicolas Maduro accountable for his country's crisis, the US State Secretary Mike Pompeo stated.

Subscribe to "Fundamental Analysis" feed

Subscribe
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.